GC1130A

· GC Biopharma Corp

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GC1130A, covering 2025-08-28 to 2025-08-28. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Study of GC1130A in Patients With Sanfilippo Syndrome Type A (MPS IIIA) [Phase 1]